TSPO: Kaleidoscopic 18-kDa amid biochemical pharmacology, control and targeting of mitochondria

Biochemical Journal

Volumn 473, Issue 2, 2016, Pages 107-121

  Gatliff, Jemma ^a   Campanella, Michelangelo ^a,b  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Autophagy; Biochemistry And Mitochondrial Pharmacology; Metabolism; Peripheral Benzodiazepine Receptor (Pbr); Steroids; Translocator Protein (TSPO)

Indexed keywords

CARRIER PROTEIN; EMAPUNIL; ETIFOXINE; MIDAZOLAM; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; REACTIVE OXYGEN METABOLITE; STEROIDOGENIC ACUTE REGULATORY PROTEIN; 4 AMINOBUTYRIC ACID RECEPTOR; BZRP PROTEIN, MOUSE; CHOLESTEROL; STEROID;

BACILLUS CEREUS; BODY WEIGHT; CHRONIC INFLAMMATION; COLORECTAL CARCINOMA; ENDOMETRIUM CARCINOMA; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; IMMUNE RESPONSE; LIPID METABOLISM; MITOCHONDRION; MOLECULAR INTERACTION; NEGATIVE FEEDBACK; NONHUMAN; OXIDATIVE STRESS; PHYLOGENY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; REDOX STRESS; REVIEW; RHODOBACTER SPHAEROIDES; SIGNAL TRANSDUCTION; STEROIDOGENESIS; AMINO ACID SEQUENCE; ANIMAL; BIOCHEMISTRY; DRUG DELIVERY SYSTEM; GENETICS; METABOLISM; MITOCHONDRIAL MEMBRANE; MOLECULAR GENETICS; TRENDS;

AMINO ACID SEQUENCE; ANIMALS; BIOCHEMICAL PHENOMENA; CHOLESTEROL; DRUG DELIVERY SYSTEMS; HUMANS; MITOCHONDRIA; MITOCHONDRIAL MEMBRANES; MOLECULAR SEQUENCE DATA; RECEPTORS, GABA; STEROIDS;

EID: 84955479528     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20150899     Document Type: Review

References (188)

1. Braestrup, C. (1977) Specific benzodiazepine receptors in rat brain characterized by high-Affinity [3H]diazepam binding. Proc. Natl. Acad. Sci. U.S.A. 74, 3805-3809
2. Anholt, R.R., Pedersen, P.L., De Souza, E.B. and Snyder, S.H. (1986) The peripheral-Type benzodiazepine receptor. Localization to the mitochondrial outer membrane. J. Biol. Chem. 261, 576-583
3. Antkiewicz-Michaluk, L., Guidotti, A. and Krueger, K.E. (1988) Molecular characterization and mitochondrial density of a recognition site for peripheral-Type benzodiazepine ligands. Mol. Pharmacol. 34, 272-278
4. Benavides, J., Guilloux, F., Rufat, P., Uzan, A., Renault, C., Dubroeucq, M.C., Gueremy, C. and Le Fur, G. (1984) In vivo labelling in several rat tissues of 'peripheral type' benzodiazepine binding sites. Eur. J. Pharmacol. 99, 1-7
5. Papadopoulos, V., Amri, H., Boujrad, N., Cascio, C., Culty, M., Garnier, M., Hardwick, M., Li, H., Vidic, B., Brown, A.S. et al. (1997) Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis. Steroids 62, 21-28
6. Anholt, R.R., De Souza, E.B., Kuhar, M.J. and Snyder, S.H. (1985) Depletion of peripheral-Type benzodiazepine receptors after hypophysectomy in rat adrenal gland and testis. Eur. J. Pharmacol. 110, 41-46
7. Papadopoulos, V., Guarneri, P., Kreuger, K.E., Guidotti, A. and Costa, E. (1992) Pregnenolone biosynthesis in C6-2B glioma cell mitochondria: regulation by a mitochondrial diazepam binding inhibitor receptor. Proc. Natl. Acad. Sci. U.S.A. 89, 5113-5117
8. Papadopoulos, V., Berkovich, A., Krueger, K.E., Costa, E. and Guidotti, A. (1991) Diazepam binding inhibitor and its processing products stimulate mitochondrial steroid biosynthesis via an interaction with mitochondrial benzodiazepine receptors. Endocrinology 129, 1481-1488
9. Li, H. and Papadopoulos, V. (1998) Peripheral-Type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern. Endocrinology 139, 4991-4997
10. Gavish, M., Bachman, I., Shoukrun, R., Katz, Y., Veenman, L., Weisinger, G. and Weizman, A. (1999) Enigma of the peripheral benzodiazepine receptor. Pharmacol. Rev. 51, 629-650
11. Papadopoulos, V., Baraldi, M., Guilarte, T.R., Knudsen, T.B., Lacapere, J.J., Lindemann, P., Norenberg, M.D., Nutt, D., Weizman, A., Zhang, M.R. et al. (2006) Translocator protein (18kDa): new nomenclature for the peripheral-Type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol. Sci. 27, 402-409
12. Liu, G.J., Middleton, R.J., Hatty, C.R., Kam, W.W., Chan, R., Pham, T., Harrison-Brown, M., Dodson, E., Veale, K., Banati, R.B. et al. (2014) The 18 kDa translocator protein, microglia and neuroinflammation. Brain Pathol. 24, 631-653
13. De Souza, E.B., Anholt, R.R., Murphy, K.M., Snyder, S.H. and Kuhar, M.J. (1985) Peripheral-Type benzodiazepine receptors in endocrine organs: Autoradiographic localization in rat pituitary, adrenal, and testis. Endocrinology 116, 567-573
14. Anholt, R.R., De Souza, E.B., Oster-Granite, M.L. and Snyder, S.H. (1985) Peripheral-Type benzodiazepine receptors: Autoradiographic localization in whole-body sections of neonatal rats. J. Pharmacol. Exp. Ther. 233, 517-526
15. Gehlert, D.R., Yamamura, H.I. and Wamsley, J.K. (1985) Autoradiographic localization of "peripheral-Type" benzodiazepine binding sites in the rat brain, heart and kidney. Naunyn Schmiedebergs Arch. Pharmacol. 328, 454-460
16. Anholt, R. (1986) The peripheral-Type benzodiazepine receptor-localization to the mitochondrial outer membrane. J. Biol. Chem. 261, 576-583
17. McEnery, M.W., Snowman, A.M., Trifiletti, R.R. and Snyder, S.H. (1992) Isolation of the mitochondrial benzodiazepine receptor: Association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proc. Natl. Acad. Sci. U.S.A. 89, 3170-3174
18. Ostuni, M.A., Issop, L., Peranzi, G., Walker, F., Fasseu, M., Elbim, C., Papadopoulos, V. and Lacapere, J.J. (2010) Overexpression of translocator protein in inflammatory bowel disease: potential diagnostic and treatment value. Inflamm. Bowel Dis. 16, 1476-1487
19. Hardwick, M., Fertikh, D., Culty, M., Li, H., Vidic, B. and Papadopoulos, V. (1999) Peripheral-Type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol. Cancer Res. 59, 831-842
20. Olson, J.M., Ciliax, B.J., Mancini, W.R. and Young, A.B. (1988) Presence of peripheral-Type benzodiazepine binding sites on human erythrocyte membranes. Eur. J. Pharmacol. 152, 47-53
21. Rupprecht, R., Papadopoulos, V., Rammes, G., Baghai, T.C., Fan, J., Akula, N., Groyer, G., Adams, D. and Schumacher, M. (2010) Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat. Rev. Drug Discov. 9, 971-988
22. Thompson, M.M., Manning, H.C. and Ellacott, K.L. (2013) Translocator protein 18 kDa (TSPO) is regulated in white and brown adipose tissue by obesity. PLoS One 8, e79980
23. Banati, R.B., Myers, R. and Kreutzberg, G.W. (1997) PK ('peripheral benzodiazepine')-binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK11195 binding to activated microglia. J. Neurocytol. 26, 77-82
24. Daugherty, D.J., Selvaraj, V., Chechneva, O.V., Liu, X.B., Pleasure, D.E. and Deng, W. (2013) A TSPO ligand is protective in a mouse model of multiple sclerosis. EMBO Mol. Med. 5, 891-903
25. Barron, A.M., Garcia-Segura, L.M., Caruso, D., Jayaraman, A., Lee, J.W., Melcangi, R.C. and Pike, C.J. (2013) Ligand for translocator protein reverses pathology in a mouse model of Alzheimer's disease. J. Neurosci. 33, 8891-8897
26. Kondo, D., Saegusa, H., Yabe, R., Takasaki, I., Kurihara, T., Zong, S. and Tanabe, T. (2009) Peripheral-Type benzodiazepine receptor antagonist is effective in relieving neuropathic pain in mice. J. Pharmacol. Sci. 110, 55-63
27. Decaudin, D., Castedo, M., Nemati, F., Beurdeley-Thomas, A., De Pinieux, G., Caron, A., Pouillart, P., Wijdenes, J., Rouillard, D., Kroemer, G. et al. (2002) Peripheral benzodiazepine receptor ligands reverse apoptosis resistance of cancer cells in vitro and in vivo. Cancer Res. 62, 1388-1393
28. Bribes, E., Bourrie, B., Esclangon, M., Galiegue, S., Vidal, H. and Casellas, P. (2002) Involvement of the peripheral benzodiazepine receptor in the development of rheumatoid arthritis in Mrl/lpr mice. Eur. J. Pharmacol. 452, 111-122
29. Gut, P., Baeza-Raja, B., Andersson, O., Hasenkamp, L., Hsiao, J., Hesselson, D., Akassoglou, K., Verdin, E., Hirschey, M.D. and Stainier, D.Y. (2013) Whole-organism screening for gluconeogenesis identifies activators of fasting metabolism. Nat. Chem. Biol. 9, 97-104
30. Obame, F.N., Zini, R., Souktani, R., Berdeaux, A. and Morin, D. (2007) Peripheral benzodiazepine receptor-induced myocardial protection is mediated by inhibition of mitochondrial membrane permeabilization. J. Pharmacol. Exp. Ther. 323, 336-345
31. Rupprecht, R., Rammes, G., Eser, D., Baghai, T.C., Schule, C., Nothdurfter, C., Troxler, T., Gentsch, C., Kalkman, H.O., Chaperon, F. et al. (2009) Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects. Science 325, 490-493
32. Banati, R.B., Middleton, R.J., Chan, R., Hatty, C.R., Kam, W.W., Quin, C., Graeber, M.B., Parmar, A., Zahra, D., Callaghan, P. et al. (2014) Positron emission tomography and functional characterization of a complete PBR/TSPO knockout. Nat. Commun. 5, 5452
33. Sileikyte, J., Blachly-Dyson, E., Sewell, R., Carpi, A., Menabo, R., Di Lisa, F., Ricchelli, F., Bernardi, P. and Forte, M. (2014) Regulation of the mitochondrial permeability transition pore by the outer membrane does not involve the peripheral benzodiazepine receptor (TSPO). J. Biol. Chem. 289, 13769-13781
34. Tu, L.N., Morohaku, K., Manna, P.R., Pelton, S.H., Butler, W.R., Stocco, D.M. and Selvaraj, V. (2014) Peripheral benzodiazepine receptor/translocator protein global knock-out mice are viable with no effects on steroid hormone biosynthesis. J. Biol. Chem. 289, 27444-27454
35. Morohaku, K., Pelton, S.H., Daugherty, D.J., Butler, W.R., Deng, W. and Selvaraj, V. (2014) Translocator protein/peripheral benzodiazepine receptor is not required for steroid hormone biosynthesis. Endocrinology 155, 89-97
36. Tu, L.N., Zhao, A.H., Stocco, D.M. and Selvaraj, V. (2015) PK11195 effect on steroidogenesis is not mediated through the translocator protein (TSPO). Endocrinology 156, 1033-1039
37. Alho, H., Harjuntausta, T., Schultz, R., Pelto-Huikko, M. and Bovolin, P. (1991) Immunohistochemistry of diazepam binding inhibitor (DBI) in the central nervous system and peripheral organs: its possible role as an endogenous regulator of different types of benzodiazepine receptors. Neuropharmacology 30, 1381-1386
38. Besman, M.J., Yanagibashi, K., Lee, T.D., Kawamura, M., Hall, P.F. and Shively, J.E. (1989) Identification of des-(Gly-Ile)-endozepine as an effector of corticotropin-dependent adrenal steroidogenesis: stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor. Proc. Natl. Acad. Sci. U.S.A. 86, 4897-4901
39. Vanhee, C., Zapotoczny, G., Masquelier, D., Ghislain, M. and Batoko, H. (2011) The Arabidopsis multistress regulator TSPO is a heme binding membrane protein and a potential scavenger of porphyrins via an autophagy-dependent degradation mechanism. Plant Cell 23, 785-805
40. Guo, Y., Kalathur, R.C., Liu, Q., Kloss, B., Bruni, R., Ginter, C., Kloppmann, E., Rost, B. and Hendrickson, W.A. (2015) Protein structure. Structure and activity of tryptophan-rich TSPO proteins. Science 347, 551-555
41. Gatliff, J., East, D., Crosby, J., Abeti, R., Harvey, R., Craigen, W., Parker, F. and Campanella, M. (2014) TSPO interacts with VDAC1 and triggers a ROS-mediated inhibition of mitochondrial quality control. Autophagy 10, 2279-2296
42. Giatzakis, C. and Papadopoulos, V. (2004) Differential utilization of the promoter of peripheral-Type benzodiazepine receptor by steroidogenic versus nonsteroidogenic cell lines and the role of Sp1 and Sp3 in the regulation of basal activity. Endocrinology 145, 1113-1123
43. Batarseh, A., Barlow, K.D., Martinez-Arguelles, D.B. and Papadopoulos, V. (2012) Functional characterization of the human translocator protein (18kDa) gene promoter in human breast cancer cell lines. Biochim. Biophys. Acta 1819, 38-56
44. Oberto, A., Longone, P. and Krueger, K.E. (1995) Identification of three transcriptional regulatory elements in the rat mitochondrial benzodiazepine receptor-encoding gene. Gene 167, 255-60
45. Giatzakis, C., Batarseh, A., Dettin, L. and Papadopoulos, V. (2007) The role of Ets transcription factors in the basal transcription of the translocator protein (18 kDa). Biochemistry 46, 4763-4774
46. Batarseh, A., Giatzakis, C. and Papadopoulos, V. (2008) Phorbol-12-myristate 13-Acetate acting through protein kinase Cepsilon induces translocator protein (18-kDa) TSPO gene expression. Biochemistry 47, 12886-12899
47. Batarseh, A., Li, J. and Papadopoulos, V. (2010) Protein kinase C epsilon regulation of translocator protein (18 kDa) Tspo gene expression is mediated through a MAPK pathway targeting STAT3 and c-Jun transcription factors. Biochemistry 49, 4766-4778
48. Batarseh, A. and Papadopoulos, V. (2010) Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states. Mol. Cell. Endocrinol. 327, 1-12
49. Kruczek, C., Gorg, B., Keitel, V., Pirev, E., Kroncke, K.D., Schliess, F. and Haussinger, D. (2009) Hypoosmotic swelling affects zinc homeostasis in cultured rat astrocytes. Glia 57, 79-92
50. Rey, C., Mauduit, C., Naureils, O., Benahmed, M., Louisot, P. and Gasnier, F. (2000) Up-regulation of mitochondrial peripheral benzodiazepine receptor expression by tumor necrosis factor alpha in testicular leydig cells. Possible involvement in cell survival. Biochem. Pharmacol. 60, 1639-1646
51. Trincavelli, M.L., Marselli, L., Falleni, A., Gremigni, V., Ragge, E., Dotta, F., Santangelo, C., Marchetti, P., Lucacchini, A. and Martini, C. (2002) Upregulation of mitochondrial peripheral benzodiazepine receptor expression by cytokine-induced damage of human pancreatic islets. J. Cell. Biochem. 84, 636-644
52. Campioli, E., Batarseh, A., Li, J. and Papadopoulos, V. (2011) The endocrine disruptor mono-(2-ethylhexyl) phthalate affects the differentiation of human liposarcoma cells (SW 872). PLoS One 6, e28750
53. Gatliff, J. and Campanella, M. (2015) TSPO is a REDOX regulator of cell mitophagy. Biochem. Soc. Trans. 43, 543-552
54. Basile, A.S., Ostrowski, N.L. and Skolnick, P. (1987) Aldosterone-reversible decrease in the density of renal peripheral benzodiazepine receptors in the rat after adrenalectomy. J. Pharmacol. Exp. Ther. 240, 1006-1013
55. Mazurika, C., Veenman, L., Weizman, R., Bidder, M., Leschiner, S., Golani, I., Spanier, I., Weisinger, G. and Gavish, M. (2009) Estradiol modulates uterine 18 kDa translocator protein gene expression in uterus and kidney of rats. Mol. Cell. Endocrinol. 307, 43-49
56. Bitran, D., Carlson, D., Leschiner, S. and Gavish, M. (1998) Ovarian steroids and stress produce changes in peripheral benzodiazepine receptor density. Eur. J. Pharmacol. 361, 235-242
57. Bar-Ami, S., Amiri, Z., Fares, F. and Gavish, M. (1994) Modulation of peripheral benzodiazepine receptors in female rat genital organs by various gonadal steroids. Life Sci. 54, 1965-1975
58. Gavish, M., Okun, F., Weizman, A. and Youdim, M.B. (1986) Modulation of peripheral benzodiazepine binding sites following chronic estradiol treatment. Eur. J. Pharmacol. 127, 147-151
59. Boujrad, N., Gaillard, J.L., Garnier, M. and Papadopoulos, V. (1994) Acute action of choriogonadotropin on Leydig tumor cells: induction of a higher affinity benzodiazepine-binding site related to steroid biosynthesis. Endocrinology 135, 1576-1583
60. Whalin, M.E., Boujrad, N., Papadopoulos, V. and Krueger, K.E. (1994) Studies on the phosphorylation of the 18 kDa mitochondrial benzodiazepine receptor protein. J. Recept. Res. 14, 217-228
61. Fan, J., Liu, J., Culty, M. and Papadopoulos, V. (2010) Acyl-coenzyme A binding domain containing 3 (ACBD3; PAP7; GCP60): An emerging signaling molecule. Prog. Lipid Res. 49, 218-234
62. Liu, J., Rone, M.B. and Papadopoulos, V. (2006) Protein-protein interactions mediate mitochondrial cholesterol transport and steroid biosynthesis. J. Biol. Chem. 281, 38879-38893
63. Chen, C., Kuo, J., Wong, A. and Micevych, P. (2014) Estradiol modulates translocator protein (TSPO) and steroid acute regulatory protein (StAR) via protein kinase A (PKA) signaling in hypothalamic astrocytes. Endocrinology 155, 2976-2985
64. Pelechano, V. and Steinmetz, L.M. (2013) Gene regulation by antisense transcription. Nat. Rev. Genet. 14, 880-893
65. Fan, J. and Papadopoulos, V. (2012) Transcriptional regulation of translocator protein (Tspo) via a SINE B2-mediated natural antisense transcript in MA-10 Leydig cells. Biol. Reprod. 86, 1-15
66. Vega, R.B., Huss, J.M. and Kelly, D.P. (2000) The coactivator PGC-1 cooperates with peroxisome proliferator-Activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol. Cell. Biol. 20, 1868-1876
67. Hardwick, M., Rone, J., Han, Z., Haddad, B. and Papadopoulos, V. (2001) Peripheral-Type benzodiazepine receptor levels correlate with the ability of human breast cancer MDA-MB-231 cell line to grow in SCID mice. Int. J. Cancer 94, 322-327
68. Gazouli, M., Yao, Z.X., Boujrad, N., Corton, J.C., Culty, M. and Papadopoulos, V. (2002) Effect of peroxisome proliferators on Leydig cell peripheral-Type benzodiazepine receptor gene expression, hormone-stimulated cholesterol transport, and steroidogenesis: role of the peroxisome proliferator-Activator receptor alpha. Endocrinology 143, 2571-2583
69. Boujrad, N., Vidic, B., Gazouli, M., Culty, M. and Papadopoulos, V. (2000) The peroxisome proliferator perfluorodecanoic acid inhibits the peripheral-Type benzodiazepine receptor (PBR) expression and hormone-stimulated mitochondrial cholesterol transport and steroid formation in Leydig cells. Endocrinology 141, 3137-3148
70. Delerive, P., Bosscher, K., Besnard, S., Berghe, W., Peters, J.M., Gonzalez, F.J., Fruchart, J.C., Tedgui, A., Haegeman, G. and Staels, B. (1999) Peroxisome proliferator-Activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-Talk with transcription factors NF-kappaB and AP-1. J. Biol. Chem. 274, 32048-32054
71. Poynter, M.E. and Daynes, R.A. (1998) Peroxisome proliferator-Activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappaB signaling, and reduces inflammatory cytokine production in aging. J. Biol. Chem. 273, 32833-32841
72. Yang, S., Chen, C., Wang, H., Rao, X., Wang, F., Duan, Q., Chen, F., Long, G., Gong, W., Zou, M.H. and Wang, D.W. (2012) Protective effects of Acyl-coA thioesterase 1 on diabetic heart via PPARalpha/PGC1alpha signaling. PLoS One 7, e50376
73. Gervois, P. and Mansouri, R.M. (2012) PPARalpha as a therapeutic target in inflammation-Associated diseases. Expert Opin. Ther. Targets 16, 1113-1125
74. Bernassau, J.M., Reversat, J.L., Ferrara, P., Caput, D. and Lefur, G. (1993) A 3D model of the peripheral benzodiazepine receptor and its implication in intra mitochondrial cholesterol transport. J. Mol. Graph. 11, 236-244
75. Joseph-Liauzun, E., Delmas, P., Shire, D. and Ferrara, P. (1998) Topological analysis of the peripheral benzodiazepine receptor in yeast mitochondrial membranes supports a five-Transmembrane structure. J. Biol. Chem. 273, 2146-2152
76. Murail, S., Robert, J.C., Coic, Y.M., Neumann, J.M., Ostuni, M.A., Yao, Z.X., Papadopoulos, V., Jamin, N. and Lacapere, J.J. (2008) Secondary and tertiary structures of the transmembrane domains of the translocator protein TSPO determined by NMR. Stabilization of the TSPO tertiary fold upon ligand binding. Biochim. Biophys. Acta 1778, 1375-1381
77. Yeliseev, A.A. and Kaplan, S. (2000) TspO of rhodobacter sphaeroides. A structural and functional model for the mammalian peripheral benzodiazepine receptor. J. Biol. Chem. 275, 5657-5667
78. Korkhov, V.M. (2010) Three-dimensional structure of TspO by electron cryomicroscopy of helical crystals. Structure 18, 677
79. Lacapere, J.J., Delavoie, F., Li, H., Peranzi, G., Maccario, J., Papadopoulos, V. and Vidic, B. (2001) Structural and functional study of reconstituted peripheral benzodiazepine receptor. Biochem. Biophys. Res. Commun. 284, 536-541
80. Jaremko, L., Jaremko, M., Giller, K., Becker, S. and Zweckstetter, M. (2014) Structure of the mitochondrial translocator protein in complex with a diagnostic ligand. Science 343, 1363-1366
81. Li, F., Xia, Y., Meiler, J. and Ferguson-Miller, S. (2013) Characterization and modeling of the oligomeric state and ligand binding behavior of purified translocator protein 18 kDa from Rhodobacter sphaeroides. Biochemistry 52, 5884-5899
82. Scarf, A.M., Auman, K.M. and Kassiou, M. (2012) Is there any correlation between binding and functional effects at the translocator protein (TSPO) (18 kDa)? Curr. Mol. Med. 12, 387-397
83. Li, H., Yao, Z., Degenhardt, B., Teper, G. and Papadopoulos, V. (2001) Cholesterol binding at the cholesterol recognition/interaction amino acid consensus (CRAC) of the peripheral-Type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide. Proc. Natl. Acad. Sci. U.S.A. 98, 1267-1272
84. Teboul, D., Beaufils, S., Taveau, J.C., Iatmanen-Harbi, S., Renault, A., Venien-Bryan, C., Vie, V. and Lacapere, J.J. (2012) Mouse TSPO in a lipid environment interacting with a functionalized monolayer. Biochim. Biophys. Acta 1818, 2791-2800
85. Delavoie, F., Li, H., Hardwick, M., Robert, J.C., Giatzakis, C., Peranzi, G., Yao, Z.X., Maccario, J., Lacapere, J.J. and Papadopoulos, V. (2003) In vivo and in vitro peripheral-Type benzodiazepine receptor polymerization: functional significance in drug ligand and cholesterol binding. Biochemistry 42, 4506-4519
86. Lacapere, J.J. and Papadopoulos, V. (2003) Peripheral-Type benzodiazepine receptor: structure and function of a cholesterol-binding protein in steroid and bile acid biosynthesis. Steroids 68, 569-585
87. Costa, B., Pini, S., Martini, C., Abelli, M., Gabelloni, P., Landi, S., Muti, M., Gesi, C., Lari, L., Cardini, A. et al. (2009) Ala147Thr substitution in translocator protein is associated with adult separation anxiety in patients with depression. Psychiatr. Genet. 19, 110-111
88. Kreisl, W.C., Jenko, K.J., Hines, C.S., Lyoo, C.H., Corona, W., Morse, C.L., Zoghbi, S.S., Hyde, T., Kleinman, J.E., Pike, V.W., McMahon, F.J. and Innis, R.B. (2013) A genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation. J. Cereb. Blood Flow Metab. 33, 53-58
89. Colasanti, A., Owen, D.R., Grozeva, D., Rabiner, E.A., Matthews, P.M., Craddock, N. and Young, A.H. (2013) Bipolar disorder is associated with the rs6971 polymorphism in the gene encoding 18 kDa translocator protein (TSPO). Psychoneuroendocrinology 38, 2826-2829
90. Costa, B., Pini, S., Gabelloni, P., Da Pozzo, E., Abelli, M., Lari, L., Preve, M., Lucacchini, A., Cassano, G.B. and Martini, C. (2009) The spontaneous Ala147Thr amino acid substitution within the translocator protein influences pregnenolone production in lymphomonocytes of healthy individuals. Endocrinology 150, 5438-5445
91. Li, F., Liu, J., Valls, L., Hiser, C. and Ferguson-Miller, S. (2015) Identification of a key cholesterol binding enhancement motif in translocator protein 18 kDa. Biochemistry 54, 1441-1443
92. Li, F., Liu, J., Zheng, Y., Garavito, R.M. and Ferguson-Miller, S. (2015) Protein structure. Crystal structures of translocator protein (TSPO) and mutant mimic of a human polymorphism. Science 347, 555-558
93. Owen, D.R., Yeo, A.J., Gunn, R.N., Song, K., Wadsworth, G., Lewis, A., Rhodes, C., Pulford, D.J., Bennacef, I., Parker, C.A. et al. (2012) An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J. Cereb. Blood Flow Metab. 32, 1-5
94. Mizrahi, R., Rusjan, P.M., Kennedy, J., Pollock, B., Mulsant, B., Suridjan, I., Luca, V., Wilson, A.A. and Houle, S. (2012) Translocator protein (18 kDa) polymorphism (rs6971) explains in-vivo brain binding affinity of the PET radioligand [(18)F]-FEPPA. J. Cereb. Blood Flow Metab. 32, 968-972
95. Yoder, K.K., Nho, K., Risacher, S.L., Kim, S., Shen, L. and Saykin, A.J. (2013) Influence of TSPO genotype on 11C-PBR28 standardized uptake values. J. Nucl. Med. 54, 1320-1322
96. Guo, Q., Colasanti, A., Owen, D.R., Onega, M., Kamalakaran, A., Bennacef, I., Matthews, P.M., Rabiner, E.A., Turkheimer, F.E. and Gunn, R.N. (2013) Quantification of the specific translocator protein signal of 18F-PBR111 in healthy humans: A genetic polymorphism effect on in vivo binding. J. Nucl. Med. 54, 1915-1923
97. Jaremko, M., Jaremko, L., Giller, K., Becker, S. and Zweckstetter, M. (2015) Structural integrity of the A147T polymorph of mammalian TSPO. ChemBioChem 16, 1483-1489
98. Miller, W.L. and Auchus, R.J. (2011) The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr. Rev. 32, 81-151
99. Epstein, L.F. and Orme-Johnson, N.R. (1991) Regulation of steroid hormone biosynthesis. Identification of precursors of a phosphoprotein targeted to the mitochondrion in stimulated rat adrenal cortex cells. J. Biol. Chem. 266, 19739-19745
100. Clark, B.J., Wells, J., King, S.R. and Stocco, D.M. (1994) The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR). J. Biol. Chem. 269, 28314-28322
101. Bose, H.S., Lingappa, V.R. and Miller, W.L. (2002) Rapid regulation of steroidogenesis by mitochondrial protein import. Nature 417, 87-91
102. Petrescu, A.D., Gallegos, A.M., Okamura, Y., Strauss, III and Schroeder, F. (2001) Steroidogenic acute regulatory protein binds cholesterol and modulates mitochondrial membrane sterol domain dynamics. J. Biol. Chem. 276, 36970-36982
103. Hauet, T., Liu, J., Li, H., Gazouli, M., Culty, M. and Papadopoulos, V. (2005) Peripheral-Type benzodiazepine receptor-mediated action of steroidogenic acute regulatory protein on cholesterol entry into leydig cell mitochondria. Mol. Endocrinol. 19, 540-554
104. Papadopoulos, V. (1993) Peripheral-Type benzodiazepine/diazepam binding inhibitor receptor: biological role in steroidogenic cell function. Endocr. Rev. 14, 222-240
105. Hauet, T., Liu, J., Li, H., Gazouli, M., Culty, M. and Papadopoulos, V. (2002) PBR, StAR, and PKA: partners in cholesterol transport in steroidogenic cells. Endocr. Res. 28, 395-401
106. Jamin, N., Neumann, J.M., Ostuni, M.A., Vu, T.K., Yao, Z.X., Murail, S., Robert, J.C., Giatzakis, C., Papadopoulos, V. and Lacapere, J.J. (2005) Characterization of the cholesterol recognition amino acid consensus sequence of the peripheral-Type benzodiazepine receptor. Mol. Endocrinol. 19, 588-594
107. Midzak, A., Akula, N., Lecanu, L. and Papadopoulos, V. (2011) Novel androstenetriol interacts with the mitochondrial translocator protein and controls steroidogenesis. J. Biol. Chem. 286, 9875-9887
108. Midzak, A.S., Akula, N., Rone, M.B. and Papadopoulos, V. (2015) Computational modeling and biological validation of novel non-steroidal ligands for the cholesterol recognition/interaction amino acid consensus (CRAC) motif of the mitochondrial translocator protein (TSPO) Pharmacol. Res. 99, 393-403
109. Rone, M.B., Fan, J. and Papadopoulos, V. (2009) Cholesterol transport in steroid biosynthesis: role of protein-protein interactions and implications in disease states. Biochim. Biophys. Acta 1791, 646-658
110. Tu, L.N., Morohaku, K., Manna, P.R., Pelton, S.H., Butler, W.R., Stocco, D.M. and Selvaraj, V. (2014) Peripheral benzodiazepine receptor/translocator protein global knockout mice are viable with no effects on steroid hormone biosynthesis. J. Biol. Chem. 289, 27444-27454
111. Fan, J., Campioli, E., Midzak, A., Culty, M. and Papadopoulos, V. (2015) Conditional steroidogenic cell-Targeted deletion of TSPO unveils a crucial role in viability and hormone-dependent steroid formation. Proc. Natl. Acad. Sci. U.S.A. 112, 7261-7266
112. Papadopoulos, V., Aghazadeh, Y., Fan, J., Campioli, E., Zirkin, B. and Midzak, A. (2015) Translocator protein-mediated pharmacology of cholesterol transport and steroidogenesis. Mol. Cell. Endocrinol. 408, 90-98
113. Taylor, J.M., Allen, A.M. and Graham, A. (2014) Targeting mitochondrial 18 kDa translocator protein (TSPO) regulates macrophage cholesterol efflux and lipid phenotype. Clin. Sci. 127, 603-613
114. Decker, C. and Faccio, R. (2015) Tmem178 is a negative regulator of bone homeostasis and osteoclast activation in mice and humans via a novel negative feedback loop targeting endoplasmic reticulum Ca2+ mobilization. Orthopaedic Research Society (ORS) Annual Meeting 2015, Las Vegas, NV, U.S.A., 27-28 March 2015, Abstract 556
115. Wang, L., Wildt, K.F., Castro, E., Xiong, Y., Feigenbaum, L., Tessarollo, L. and Bosselut, R. (2008) The zinc finger transcription factor Zbtb7b represses CD8-lineage gene expression in peripheral CD4+ T cells. Immunity 29, 876-887
116. Enders, A., Stankovic, S., Teh, C., Uldrich, A.P., Yabas, M., Juelich, T., Altin, J.A., Frankenreiter, S., Bergmann, H., Roots, C.M. et al. (2012) ZBTB7B (Th-POK) regulates the development of IL-17-producing CD1d-restricted mouse NKT cells. J. Immunol. 189, 5240-5249
117. Zhou, T., Dang, Y. and Zheng, Y.H. (2014) The mitochondrial translocator protein, TSPO, inhibits HIV-1 envelope glycoprotein biosynthesis via the endoplasmic reticulum-Associated protein degradation pathway. J. Virol. 88, 3474-3784
118. Brunette, R.L., Young, J.M., Whitley, D.G., Brodsky, I.E., Malik, H.S. and Stetson, D.B. (2012) Extensive evolutionary and functional diversity among mammalian AIM2-like receptors. J. Exp. Med. 209, 1969-1983
119. Chen, L. and Yang, G. (2014) PPARs integrate the mammalian clock and energy metabolism. PPAR Res. 2014, 653017
120. Yang, X., Zhang, Y.K., Esterly, N., Klaassen, C.D. and Wan, Y.J. (2009) Gender disparity of hepatic lipid homoeostasis regulated by the circadian clock. J. Biochem. 145, 609-623
121. Maury, E., Ramsey, K.M. and Bass, J. (2010) Circadian rhythms and metabolic syndrome: from experimental genetics to human disease. Circ. Res. 106, 447-462
122. Golani, I., Weizman, A., Leschiner, S., Spanier, I., Eckstein, N., Limor, R., Yanai, J., Maaser, K., Scherübl, H., Weisinger, G. et al. (2001) Hormonal regulation of peripheral benzodiazepine receptor binding properties is mediated by subunit interaction. Biochemistry 40, 10213-10222
123. Papadopoulos, V., Boujrad, N., Ikonomovic, M.D., Ferrara, P. and Vidic, B. (1994) Topography of the Leydig cell mitochondrial peripheral-Type benzodiazepine receptor. Mol. Cell. Endocrinol. 104, R5-R9
124. Aghazadeh, Y., Martinez-Arguelles, D.B., Fan, J., Culty, M. and Papadopoulos, V. (2014) Induction of androgen formation in the male by a TAT-VDAC1 fusion peptide blocking 14-3-3varepsilon protein adaptor and mitochondrial VDAC1 interactions. Mol. Ther. 22, 1779-1791
125. Campanella, M. (2014) Peptide targeting of mitochondria elicits testosterone formation. Mol. Ther. 22, 1727-1729
126. Doperalski, N.J., Martyniuk, C.J., Prucha, M.S., Kroll, K.J., Denslow, N.D. and Barber, D.S. (2011) Cloning and expression of the translocator protein (18 kDa), voltage-dependent anion channel, and diazepam binding inhibitor in the gonad of largemouth bass (Micropterus salmoides) across the reproductive cycle. Gen. Comp. Endocrinol. 173, 86-95
127. Aghazadeh, Y., Rone, M.B., Blonder, J., Ye, X., Veenstra, T.D., Hales, D.B., Culty, M. and Papadopoulos, V. (2012) Hormone-induced 14-3-3gamma adaptor protein regulates steroidogenic acute regulatory protein activity and steroid biosynthesis in MA-10 Leydig cells. J. Biol. Chem. 287, 15380-15394
128. Rosenberg, N., Rosenberg, O., Weizman, A., Veenman, L. and Gavish, M. (2014) In vitro effect of FGIN-1-27, a ligand to 18 kDa mitochondrial translocator protein, in human osteoblast-like cells. J. Bioenerg. Biomembr. 46, 197-204
129. Rosenberg, N., Rosenberg, O., Weizman, A., Veenman, L. and Gavish, M. (2013) In vitro catabolic effect of protoporphyrin IX in human osteoblast-like cells: possible role of the 18 kDa mitochondrial translocator protein. J. Bioenerg. Biomembr. 45, 333-341
130. Rosenberg, N., Rosenberg, O., Weizman, A., Leschiner, S., Sakoury, Y., Fares, F., Soudry, M., Weisinger, G., Veenman, L. and Gavish, M. (2011) In vitro mitochondrial effects of PK 11195, a synthetic translocator protein 18 kDa (TSPO) ligand, in human osteoblast-like cells. J. Bioenerg. Biomembr. 43, 739-746
131. Amitani, M., Ohashi, A., Hatazawa, J., Gee, A. and Inoue, O. (2008) Effect of PK11195 on attenuating the enhancement of glucose utilization induced by quinolinic acid infusion in the rat brain. Synapse 62, 253-258
132. Joo, H.K., Lee, Y.R., Lim, S.Y., Lee, E.J., Choi, S., Cho, E.J., Park, M.S., Ryoo, S., Park, J.B. and Jeon, B.H. (2012) Peripheral benzodiazepine receptor regulates vascular endothelial activations via suppression of the voltage-dependent anion channel-1. FEBS Lett. 586, 1349-1355
133. Cho, J.H., Park, J.H., Chung, C.G., Shim, H.J., Jeon, K.H., Yu, S.W. and Lee, S.B. (2015) Parkin-mediated responses against infection and wound involve TSPO-VDAC complex in Drosophila. Biochem. Biophys. Res. Commun. 463, 1-6
134. Raghavan, A., Sheiko, T., Graham, B.H. and Craigen, W.J. (2012) Voltage-dependant anion channels: novel insights into isoform function through genetic models. Biochim. Biophys. Acta 1818, 1477-1485
135. Miettinen, H., Kononen, J., Haapasalo, H., Helen, P., Sallinen, P., Harjuntausta, T., Helin, H. and Alho, H. (1995) Expression of peripheral-Type benzodiazepine receptor and diazepam binding inhibitor in human astrocytomas: relationship to cell proliferation. Cancer Res. 55, 2691-2695
136. Fafalios, A., Akhavan, A., Parwani, A.V., Bies, R.R., McHugh, K.J. and Pflug, B.R. (2009) Translocator protein blockade reduces prostate tumor growth. Clin. Cancer Res. 15, 6177-6184
137. Nagler, R., Ben-Izhak, O., Savulescu, D., Krayzler, E., Akrish, S., Leschiner, S., Otradnov, I., Zeno, S., Veenman, L. and Gavish, M. (2010) Oral cancer, cigarette smoke and mitochondrial 18kDa translocator protein (TSPO)-in vitro, in vivo, salivary analysis. Biochim. Biophys. Acta 1802, 454-461
138. Konigsrainer, I., Vogel, U.F., Beckert, S., Sotlar, K., Coerper, S., Braun, A., Lembert, N., Steurer, W., Konigsrainer, A. and Kupka, S. (2007) Increased translocator protein (TSPO) mRNA levels in colon but not in rectum carcinoma. Eur. Surg. Res. 39, 359-363
139. Beinlich, A., Strohmeier, R., Kaufmann, M. and Kuhl, H. (2000) Relation of cell proliferation to expression of peripheral benzodiazepine receptors in human breast cancer cell lines. Biochem. Pharmacol. 60, 397-402
140. Galiegue, S., Casellas, P., Kramar, A., Tinel, N. and Simony-Lafontaine, J. (2004) Immunohistochemical assessment of the peripheral benzodiazepine receptor in breast cancer and its relationship with survival. Clin. Cancer Res. 10, 2058-2064
141. Sutter, A.P., Maaser, K., Hopfner, M., Barthel, B., Grabowski, P., Faiss, S., Carayon, P., Zeitz, M. and Scherubl, H. (2002) Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human esophageal cancer cells. Int. J. Cancer 102, 318-327
142. Batra, S. and Iosif, C.S. (2000) Peripheral benzodiazepine receptor in human endometrium and endometrial carcinoma. Anticancer Res. 20, 463-466
143. Lavisse, S., Guillermier, M., Herard, A.S., Petit, F., Delahaye, M., Camp, N., Ben Haim, L., Lebon, V., Remy, P., Dolĺe, F. et al. (2012) Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging. J. Neurosci. 32, 10809-10818
144. Owen, D.R. and Matthews, P.M. (2011) Imaging brain microglial activation using positron emission tomography and translocator protein-specific radioligands. Int. Rev. Neurobiol. 101, 19-39
145. Libby, P., Tabas, I., Fredman, G. and Fisher, E.A. (2014) Inflammation and its resolution as determinants of acute coronary syndromes. Circ. Res. 114, 1867-1879
146. Kumar, A., Muzik, O., Shandal, V., Chugani, D., Chakraborty, P. and Chugani, H.T. (2012) Evaluation of age-related changes in translocator protein (TSPO) in human brain using (11)C-[R]-PK11195 PET. J. Neuroinflammation 9, 232
147. Corcia, P., Tauber, C., Vercoullie, J., Arlicot, N., Prunier, C., Praline, J., Nicolas, G., Venel, Y., Hommet, C., Baulieu, J.L. et al. (2012) Molecular imaging of microglial activation in amyotrophic lateral sclerosis. PLoS One 7, e52941
148. Yasuno, F., Kosaka, J., Ota, M., Higuchi, M., Ito, H., Fujimura, Y., Nozaki, S., Takahashi, S., Mizukami, K., Asada, T. and Suhara, T. (2012) Increased binding of peripheral benzodiazepine receptor in mild cognitive impairment-dementia converters measured by positron emission tomography with [(1)(1)C]DAA1106. Psychiatry Res. 203, 67-74
149. Cagnin, A., Brooks, D.J., Kennedy, A.M., Gunn, R.N., Myers, R., Turkheimer, F.E., Jones, T. and Banati, R.B. (2001) In-vivo measurement of activated microglia in dementia. Lancet 358, 461-467
150. Varrone, A., Mattsson, P., Forsberg, A., Takano, A., Nag, S., Gulyas, B., Borg, J., Boellaard, R., Al-Tawil, N., Eriksdotter, M. et al. (2013) In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA and PET does not show increased binding in Alzheimer's disease patients. Eur. J. Nucl. Med. Mol. Imaging 40, 921-931
151. Maia, S., Arlicot, N., Vierron, E., Bodard, S., Vergote, J., Guilloteau, D. and Chalon, S. (2012) Longitudinal and parallel monitoring of neuroinflammation and neurodegeneration in a 6-hydroxydopamine rat model of Parkinson's disease. Synapse 66, 573-583
152. Ouchi, Y., Yoshikawa, E., Sekine, Y., Futatsubashi, M., Kanno, T., Ogusu, T. and Torizuka, T. (2005) Microglial activation and dopamine terminal loss in early Parkinson's disease. Ann. Neurol. 57, 168-175
153. Gerhard, A., Pavese, N., Hotton, G., Turkheimer, F., Es, M., Hammers, A., Eggert, K., Oertel, W., Banati, R.B. and Brooks, D.J. (2006) In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease. Neurobiol. Dis. 21, 404-412
154. Gulyas, B., Toth, M., Schain, M., Airaksinen, A., Vas, A., Kostulas, K., Lindstrom, P., Hillert, J. and Halldin, C. (2012) Evolution of microglial activation in ischaemic core and peri-infarct regions after stroke: A PET study with the TSPO molecular imaging biomarker [((11))C]vinpocetine. J. Neurol. Sci. 320, 110-117
155. Cuhlmann, S., Gsell, W., Van der Heiden, K., Habib, J., Tremoleda, J.L., Khalil, M., Turkheimer, F., Meens, M.J., Kwak, B.R., Bird, J. et al. (2014) In vivo mapping of vascular inflammation using the translocator protein tracer 18F-FEDAA1106. Mol. Imaging 13, 1-11
156. Bird, J.L., Izquierdo-Garcia, D., Davies, J.R., Rudd, J.H., Probst, K.C., Figg, N., Clark, J.C., Weissberg, P.L., Davenport, A.P. and Warburton, E.A. (2010) Evaluation of translocator protein quantification as a tool for characterising macrophage burden in human carotid atherosclerosis. Atherosclerosis 210, 388-391
157. Karlstetter, M., Nothdurfter, C., Aslanidis, A., Moeller, K., Horn, F., Scholz, R., Neumann, H., Weber, B.H., Rupprecht, R. and Langmann, T. (2014) Translocator protein (18 kDa) (TSPO) is expressed in reactive retinal microglia and modulates microglial inflammation and phagocytosis. J. Neuroinflammation 11, 3
158. Zhao, Y.Y., Yu, J.Z., Li, Q.Y., Ma, C.G., Lu, C.Z. and Xiao, B.G. (2011) TSPO-specific ligand vinpocetine exerts a neuroprotective effect by suppressing microglial inflammation. Neuron. Glia Biol. 7, 187-197
159. Fur, G., Perrier, M.L., Vaucher, N., Imbault, F., Flamier, A., Benavides, J., Uzan, A., Renault, C., Dubroeucq, M.C. and Gueremy, C. (1983) Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide. I. In vitro studies. Life Sci. 32, 1839-1847
160. Verma, A., Nye, J.S. and Snyder, S.H. (1987) Porphyrins are endogenous ligands for the mitochondrial (peripheral-Type) benzodiazepine receptor. Proc. Natl. Acad. Sci. U.S.A. 84, 2256-2260
161. Pastorino, J.G., Simbula, G., Gilfor, E., Hoek, J.B., Farber, J.L. and Protoporphyrin, I.X. (1994) An endogenous ligand of the peripheral benzodiazepine receptor, potentiates induction of the mitochondrial permeability transition and the killing of cultured hepatocytes by rotenone. J. Biol. Chem. 269, 31041-31046
162. Gonzalez-Polo, R.A., Carvalho, G., Braun, T., Decaudin, D., Fabre, C., Larochette, N., Perfettini, J.L., Djavaheri-Mergny, M., Youlyouz-Marfak, I., Codogno, P. et al. (2005) PK11195 potently sensitizes to apoptosis induction independently from the peripheral benzodiazepin receptor. Oncogene 24, 7503-7513
163. Gastaldello, A., Callaghan, H., Gami, P. and Campanella, M. (2010) Ca2+-dependent autophagy is enhanced by the pharmacological agent PK: pharmacological tools in autophagy. Autophagy 6, 607-613
164. Fur, G., Guilloux, F., Rufat, P., Benavides, J., Uzan, A., Renault, C., Dubroeucq, M.C. and Gueremy, C. (1983) Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-(1-methylpropyl)-3 isoquinolinecarboxamide. II. In vivo studies. Life Sci. 32, 1849-1856
165. Casellas, P., Galiegue, S. and Basile, A.S. (2002) Peripheral benzodiazepine receptors and mitochondrial function. Neurochem. Int. 40, 475-486
166. Romeo, E., Auta, J., Kozikowski, A.P., Ma, D., Papadopoulos, V., Puia, G., Costa, E. and Guidotti, A. (1992) 2-Aryl-3-indoleacetamides (FGIN-1): A new class of potent and specific ligands for the mitochondrial DBI receptor (MDR). J. Pharmacol. Exp. Ther. 262, 971-978
167. Guillon, J., Boulouard, M., Lelong, V., Dallemagne, P., Rault, S. and Jarry, C. (2001) Synthesis and preliminary behavioural evaluation in mice of new 3-Aryl-3-pyrrol-1-ylpropanamides, analogues of FGIN-1-27 and FGIN-1-43. J. Pharm. Pharmacol. 53, 1561-1568
168. Chauveau, F., Boutin, H., Camp, N., Thominiaux, C., Hantraye, P., Rivron, L., Marguet, F., Castel, M.N., Rooney, T., Benavides, J. et al. (2011) In vivo imaging of neuroinflammation in the rodent brain with [11C]SSR180575, a novel indoleacetamide radioligand of the translocator protein (18 kDa). Eur. J. Nucl. Med. Mol. Imaging 38, 509-514
169. Tang, D., Nickels, M.L., Tantawy, M.N., Buck, J.R. and Manning, H.C. (2014) Preclinical imaging evaluation of novel TSPO-PET ligand 2-(5,7-diethyl-2-(4-(2-[F]fluoroethoxy)phenyl)pyrazolo[1,5-A]pyrimidin-3-yl)-N,N-diethylacetamide ([F]VUIIS1008) in glioma. Mol. Imaging Biol. 16, 813-820
170. Selvaraj, V. and Stocco, D.M. (2015) The changing landscape in translocator protein (TSPO) function. Trends Endocrinol. Metab. 26, 341-348
171. Li, X.B., Guo, H.L., Shi, T.Y., Yang, L., Wang, M., Zhang, K., Guo, Y.Y., Wu, Y.M., Liu, S.B. and Zhao, M.G. (2015) Neuroprotective effects of a novel translocator protein (18 kDa) ligand, ZBD-2, against focal cerebral ischemia in vivo and NMDA-induced neurotoxicity in vitro. Clin. Exp. Pharmacol. Physiol. 42, 1068-1074
172. Arbo, B.D., Benetti, F., Garcia-Segura, L.M. and Ribeiro, M.F. (2015) Therapeutic actions of translocator protein (18kDa) ligands in experimental models of psychiatric disorders and neurodegenerative diseases. J. Steroid Biochem. Mol. Biol. 154, 68-74
173. Owen, D.R., Lewis, A.J., Reynolds, R., Rupprecht, R., Eser, D., Wilkins, M.R., Bennacef, I., Nutt, D.J. and Parker, C.A. (2011) Variation in binding affinity of the novel anxiolytic XBD173 for the 18 kDa translocator protein in human brain. Synapse 65, 257-259
174. Xiao, J., Liang, D., Zhang, H., Liu, Y., Li, F. and Chen, Y.H. (2010) 4'-Chlorodiazepam, a translocator protein (18 kDa) antagonist, improves cardiac functional recovery during postischemia reperfusion in rats. Exp. Biol. Med. 235, 478-486
175. Schaller, S., Paradis, S., Ngoh, G.A., Assaly, R., Buisson, B., Drouot, C., Ostuni, M.A., Lacapere, J.J., Bassissi, F., Bordet, T. et al. (2010) TRO40303, a new cardioprotective compound, inhibits mitochondrial permeability transition. J. Pharmacol. Exp. Ther. 333, 696-706
176. Wang, D.S., Tian, Z., Guo, Y.Y., Guo, H.L., Kang, W.B., Li, S., Den, Y.T., Li, X.B., Feng, B., Feng, D. et al. (2015) Anxiolytic-like effects of translocator protein (TSPO) ligand ZBD-2 in an animal model of chronic pain. Mol. pain 11, 16
177. Miao, Y.L., Guo, W.Z., Shi, W.Z., Fang, W.W., Liu, Y., Liu, J., Li, B.W., Wu, W. and Li, Y.F. (2014) Midazolam ameliorates the behavior deficits of a rat posttraumatic stress disorder model through dual 18 kDa translocator protein and central benzodiazepine receptor and neurosteroidogenesis. PLoS One 9, e101450
178. Zhang, L.M., Qiu, Z.K., Zhao, N., Chen, H.X., Liu, Y.Q., Xu, J.P., Zhang, Y.Z., Yang, R.F. and Li, Y.F. (2014) Anxiolytic-like effects of YL-IPA08, a potent ligand for the translocator protein (18 kDa) in animal models of post-Traumatic stress disorder. Int. J. Neuropsychopharmacol. 17, 1659-1669
179. Zhang, L.M., Zhao, N., Guo, W.Z., Jin, Z.L., Qiu, Z.K., Chen, H.X., Xue, R., Zhang, Y.Z., Yang, R.F. and Li, Y.F. (2014) Antidepressant-like and anxiolytic-like effects of YL-IPA08, a potent ligand for the translocator protein (18 kDa). Neuropharmacology 81, 116-125
180. Soustiel, J.F., Palzur, E., Vlodavsky, E., Veenman, L. and Gavish, M. (2008) The effect of oxygenation level on cerebral post-Traumatic apoptotsis is modulated by the 18-kDa translocator protein (also known as peripheral-Type benzodiazepine receptor) in a rat model of cortical contusion. Neuropathol. Appl. Neurobiol. 34, 412-423
181. Paradis, S., Leoni, V., Caccia, C., Berdeaux, A. and Morin, D. (2013) Cardioprotection by the TSPO ligand 4'-chlorodiazepam is associated with inhibition of mitochondrial accumulation of cholesterol at reperfusion. Cardiovasc. Res. 98, 420-427
182. Mills, C., Makwana, M., Wallace, A., Benn, S., Schmidt, H., Tegeder, I., Costigan, M., Brown, R.H. Jr., Raivich, G. and Woolf, C.J. (2008) Ro5-4864 promotes neonatal motor neuron survival and nerve regeneration in adult rats. Eur. J. Neurosci. 27, 937-946
183. Giatti, S., Pesaresi, M., Cavaletti, G., Bianchi, R., Carozzi, V., Lombardi, R., Maschi, O., Lauria, G., Garcia-Segura, L.M., Caruso, D. and Melcangi, R.C. (2009) Neuroprotective effects of a ligand of translocator protein-18 kDa (Ro5-4864) in experimental diabetic neuropathy. Neuroscience 164, 520-529
184. Costa, B., Da Pozzo, E., Chelli, B., Simola, N., Morelli, M., Luisi, M., Maccheroni, M., Taliani, S., Simorini, F., Da Settimo, F. and Martini, C. (2011) Anxiolytic properties of a 2-phenylindolglyoxylamide TSPO ligand: Stimulation of in vitro neurosteroid production affecting GABAA receptor activity. Psychoneuroendocrinology 36, 463-472
185. Shoukrun, R., Veenman, L., Shandalov, Y., Leschiner, S., Spanier, I., Karry, R., Katz, Y., Weisinger, G., Weizman, A. and Gavish, M. (2008) The 18-kDa translocator protein, formerly known as the peripheral-Type benzodiazepine receptor, confers proapoptotic and antineoplastic effects in a human colorectal cancer cell line. Pharmacogenet. Genomics 18, 977-988
186. Wei, X.H., Wei, X., Chen, F.Y., Zang, Y., Xin, W.J., Pang, R.P., Chen, Y., Wang, J., Li, Y.Y., Shen, K.F. et al. (2013) The upregulation of translocator protein (18 kDa) promotes recovery from neuropathic pain in rats. J. Neurosci. 33, 1540-1551
187. Bribes, E., Bourrie, B. and Casellas, P. (2003) Ligands of the peripheral benzodiazepine receptor have therapeutic effects in pneumopathies in vivo. Immunol. Lett. 88, 241-247
188. Kita, A., Kohayakawa, H., Kinoshita, T., Ochi, Y., Nakamichi, K., Kurumiya, S., Furukawa, K. and Oka, M. (2004) Antianxiety and antidepressant-like effects of AC-5216, a novel mitochondrial benzodiazepine receptor ligand. Br. J. Pharmacol. 142, 1059-1072